[RDY] YoY Quarter Result on 31-Dec-2019 [#Q3]

Stock
[RDY] Dr. Reddy's Laboratories Limited
Announcement Date
15-Jun-2020
Financial Year
2020
Quarter
31-Dec-2019 [#Q3]
Profit Trend
QoQ- -152.15%
YoY- -217.42%
Quarter Report
RDY's Result
RDY's Financial Summary
View:
Show?
Quarter Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 67,700,000 53,197,000 49,296,000 43,838,000 38,500,000 38,060,000 37,065,000 10.55%
PBT 16,346,000 9,709,000 2,843,000 -5,274,000 5,805,000 5,945,000 5,922,000 18.42%
Tax 3,875,000 2,644,000 2,645,000 423,000 953,000 2,601,000 1,221,000 21.21%
NP 12,471,000 7,065,000 198,000 -5,697,000 4,852,000 3,344,000 4,701,000 17.64%
Tax Rate -23.71% -27.23% -93.04% - -16.42% -43.75% -20.62% -
Total Cost 55,229,000 46,132,000 49,098,000 49,535,000 33,648,000 34,716,000 32,364,000 9.31%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin 18.42 13.28 0.40 -13.00 12.60 8.79 12.68 6.41%
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS 75.53 42.58 1.19 -34.37 29.25 20.16 28.38 17.71%
EPS Diluted 74.96 42.48 1.19 -34.37 29.21 20.13 28.32 17.60%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.